Referred to as PD01 best generic viagra.

AFFiRiS AG develops PD01 vaccine for Parkinson’s disease Today AFFiRiS AG announced an important step of progress in the advancement of its vaccine for Parkinson’s disease. The vaccine, referred to as PD01, has undergone several preclinical tests that have confirmed its principle of actions . The organization is now starting to plan medical trials of the vaccine which are planned to commence at the start of 2011 best generic viagra . Due to a totally innovative effect approach this vaccine could for the first time offer a potential for treating the sources of Parkinson’s disease. The basis of PD01 may be the company’s AFFITOM technology, on which two vaccines for Alzheimer’s disease are centered that have already effectively completed their initial scientific research.